Your Article Summary
See Latest ArticlesCD44 variant isoforms in head and neck squamous cell carcinoma progression
The Laryngoscope, 06/10/09
Wang SJ et al. - CD44 isoforms mediate migration, proliferation, and cisplatin sensitivity in HNSCC. Furthermore, expression of certain CD44 variants may be important molecular markers for HNSCC progression and should be investigated as potential therapeutic targets for therapy.
Related Articles
Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09
Relevance Score: 71%
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09
Relevance Score: 71%
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09
Relevance Score: 69%
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 69%
Progesterone receptors identified in vascular malformations of the head and neck
Otolaryngology Head and Neck Surgery, 10/09/09
Relevance Score: 69%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Study on TP53 Codon 72 Polymorphisms with Oral Carcinoma Susceptibility
Archives of Medical Research, 12/18/09
Role of the otolaryngologist in the treatment of struma ovarii
The Laryngoscope, 12/16/09
Association of the tumor necrosis factor-alpha -308 G/A polymorphism with nasal polyposis
European Archives of Oto-Rhino-Laryngology, 12/16/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Secondary surgery in paediatric facial paralysis reanimation
Journal of Plastic, Reconstructive & Aesthetic Surgery, 12/18/09
Dizziness and vertigo in an older population: the Blue Mountains prospective cross-sectional study
Clinical Otolaryngology, 12/18/09
When will I see you again? Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients
Clinical Otolaryngology, 12/18/09